Business News • PR NewsWire • Cleveland HeartLab Presents Research Demonstrating its Prognostic Tests can save $180 Million in Healthcare costs related to Cardiovascular Disease, the Number One killer of Men and Women in the US

Cleveland HeartLab Presents Research Demonstrating its Prognostic Tests can save $180 Million in Healthcare costs related to Cardiovascular Disease, the Number One killer of Men and Women in the US

Cleveland HeartLab Presents Research Demonstrating its Prognostic Tests can save $180 Million in Healthcare costs related to Cardiovascular Disease, the Number One killer of Men and Women in the US

CLEVELAND, June 2, 2014 /PRNewswire/ -- Cleveland HeartLab (CHL), a premier cardiovascular disease (CVD) management company, will present new research today at the International Society of PharmacoEconomics and Outcomes Research (ISPOR) Annual Meeting that demonstrates...

View More : http://www.prnewswire.com/news-releases/cleveland-heartlab-presents-research-demonstrating-its-prognostic-tests-can-save...

Releted News by prnewswire

Survey Shows America Needs Inflation

Public's Perception Of Clinical Trials Presented At Seminar Sponsored By inVentiv Clinical Trial Recruitment Solutions

Nearly half of Americans polled "check in" at work while on vacation according to new Travel Leaders Group survey

Cleveland HeartLab Presents Research Demonstrating its Prognostic Tests can save $180 Million in Healthcare costs related to Cardiovascular Disease, the Number One killer of Men and Women in the US